nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.153	0.196	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.153	0.196	CbGbCtD
Fluvoxamine—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.114	0.147	CbGbCtD
Fluvoxamine—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0923	0.119	CbGbCtD
Fluvoxamine—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0768	0.0987	CbGbCtD
Fluvoxamine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0745	0.0958	CbGbCtD
Fluvoxamine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0702	0.0902	CbGbCtD
Fluvoxamine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0446	0.0574	CbGbCtD
Fluvoxamine—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00583	0.0263	CcSEcCtD
Fluvoxamine—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.00493	0.0222	CcSEcCtD
Fluvoxamine—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.0201	CcSEcCtD
Fluvoxamine—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.0169	CcSEcCtD
Fluvoxamine—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.0164	CcSEcCtD
Fluvoxamine—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.014	CcSEcCtD
Fluvoxamine—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00303	0.0136	CcSEcCtD
Fluvoxamine—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00303	0.0136	CcSEcCtD
Fluvoxamine—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.013	CcSEcCtD
Fluvoxamine—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.013	CcSEcCtD
Fluvoxamine—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.0126	CcSEcCtD
Fluvoxamine—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.0122	CcSEcCtD
Fluvoxamine—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.0116	CcSEcCtD
Fluvoxamine—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.0113	CcSEcCtD
Fluvoxamine—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.0112	CcSEcCtD
Fluvoxamine—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.011	CcSEcCtD
Fluvoxamine—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.0109	CcSEcCtD
Fluvoxamine—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.0105	CcSEcCtD
Fluvoxamine—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.0101	CcSEcCtD
Fluvoxamine—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.0101	CcSEcCtD
Fluvoxamine—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.01	CcSEcCtD
Fluvoxamine—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.00987	CcSEcCtD
Fluvoxamine—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.00943	CcSEcCtD
Fluvoxamine—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00909	CcSEcCtD
Fluvoxamine—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00903	CcSEcCtD
Fluvoxamine—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00903	CcSEcCtD
Fluvoxamine—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00896	CcSEcCtD
Fluvoxamine—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00884	CcSEcCtD
Fluvoxamine—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00878	CcSEcCtD
Fluvoxamine—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00878	CcSEcCtD
Fluvoxamine—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00872	CcSEcCtD
Fluvoxamine—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00872	CcSEcCtD
Fluvoxamine—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00861	CcSEcCtD
Fluvoxamine—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00861	CcSEcCtD
Fluvoxamine—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00855	CcSEcCtD
Fluvoxamine—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00793	CcSEcCtD
Fluvoxamine—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.00779	CcSEcCtD
Fluvoxamine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.00766	CcSEcCtD
Fluvoxamine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00745	CcSEcCtD
Fluvoxamine—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00729	CcSEcCtD
Fluvoxamine—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00725	CcSEcCtD
Fluvoxamine—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00725	CcSEcCtD
Fluvoxamine—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00717	CcSEcCtD
Fluvoxamine—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00717	CcSEcCtD
Fluvoxamine—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00692	CcSEcCtD
Fluvoxamine—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00688	CcSEcCtD
Fluvoxamine—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00675	CcSEcCtD
Fluvoxamine—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00662	CcSEcCtD
Fluvoxamine—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00659	CcSEcCtD
Fluvoxamine—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00656	CcSEcCtD
Fluvoxamine—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0065	CcSEcCtD
Fluvoxamine—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00644	CcSEcCtD
Fluvoxamine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00644	CcSEcCtD
Fluvoxamine—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00641	CcSEcCtD
Fluvoxamine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00638	CcSEcCtD
Fluvoxamine—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00626	CcSEcCtD
Fluvoxamine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00621	CcSEcCtD
Fluvoxamine—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00613	CcSEcCtD
Fluvoxamine—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00608	CcSEcCtD
Fluvoxamine—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00605	CcSEcCtD
Fluvoxamine—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00602	CcSEcCtD
Fluvoxamine—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00597	CcSEcCtD
Fluvoxamine—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00592	CcSEcCtD
Fluvoxamine—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.0059	CcSEcCtD
Fluvoxamine—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.0059	CcSEcCtD
Fluvoxamine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00587	CcSEcCtD
Fluvoxamine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00576	CcSEcCtD
Fluvoxamine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00571	CcSEcCtD
Fluvoxamine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00567	CcSEcCtD
Fluvoxamine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00567	CcSEcCtD
Fluvoxamine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00545	CcSEcCtD
Fluvoxamine—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00528	CcSEcCtD
Fluvoxamine—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0052	CcSEcCtD
Fluvoxamine—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00509	CcSEcCtD
Fluvoxamine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00508	CcSEcCtD
Fluvoxamine—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00501	CcSEcCtD
Fluvoxamine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.00498	CcSEcCtD
Fluvoxamine—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00488	CcSEcCtD
Fluvoxamine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00485	CcSEcCtD
Fluvoxamine—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00479	CcSEcCtD
Fluvoxamine—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00477	CcSEcCtD
Fluvoxamine—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00465	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00462	CcSEcCtD
Fluvoxamine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0046	CcSEcCtD
Fluvoxamine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00453	CcSEcCtD
Fluvoxamine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000999	0.0045	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000996	0.00449	CcSEcCtD
Fluvoxamine—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00099	0.00446	CcSEcCtD
Fluvoxamine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000982	0.00442	CcSEcCtD
Fluvoxamine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00097	0.00437	CcSEcCtD
Fluvoxamine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000968	0.00436	CcSEcCtD
Fluvoxamine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000965	0.00435	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000965	0.00435	CcSEcCtD
Fluvoxamine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00096	0.00432	CcSEcCtD
Fluvoxamine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00096	0.00432	CcSEcCtD
Fluvoxamine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000957	0.00431	CcSEcCtD
Fluvoxamine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000957	0.00431	CcSEcCtD
Fluvoxamine—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000939	0.00423	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000931	0.0042	CcSEcCtD
Fluvoxamine—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000928	0.00418	CcSEcCtD
Fluvoxamine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000924	0.00416	CcSEcCtD
Fluvoxamine—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.000888	0.004	CcSEcCtD
Fluvoxamine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000886	0.00399	CcSEcCtD
Fluvoxamine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000884	0.00398	CcSEcCtD
Fluvoxamine—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000884	0.00398	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000879	0.00396	CcSEcCtD
Fluvoxamine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000877	0.00395	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000873	0.00393	CcSEcCtD
Fluvoxamine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000866	0.0039	CcSEcCtD
Fluvoxamine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000852	0.00384	CcSEcCtD
Fluvoxamine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000824	0.00371	CcSEcCtD
Fluvoxamine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000802	0.00361	CcSEcCtD
Fluvoxamine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000793	0.00357	CcSEcCtD
Fluvoxamine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000789	0.00356	CcSEcCtD
Fluvoxamine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000781	0.00352	CcSEcCtD
Fluvoxamine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000774	0.00349	CcSEcCtD
Fluvoxamine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000769	0.00347	CcSEcCtD
Fluvoxamine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.00342	CcSEcCtD
Fluvoxamine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000755	0.0034	CcSEcCtD
Fluvoxamine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000753	0.0034	CcSEcCtD
Fluvoxamine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000747	0.00337	CcSEcCtD
Fluvoxamine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00074	0.00333	CcSEcCtD
Fluvoxamine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000725	0.00327	CcSEcCtD
Fluvoxamine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000721	0.00325	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000714	0.00322	CcSEcCtD
Fluvoxamine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000711	0.0032	CcSEcCtD
Fluvoxamine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000707	0.00319	CcSEcCtD
Fluvoxamine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000703	0.00317	CcSEcCtD
Fluvoxamine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000694	0.00313	CcSEcCtD
Fluvoxamine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000691	0.00311	CcSEcCtD
Fluvoxamine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000689	0.0031	CcSEcCtD
Fluvoxamine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000671	0.00303	CcSEcCtD
Fluvoxamine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000667	0.003	CcSEcCtD
Fluvoxamine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000664	0.00299	CcSEcCtD
Fluvoxamine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000655	0.00295	CcSEcCtD
Fluvoxamine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000655	0.00295	CcSEcCtD
Fluvoxamine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000655	0.00295	CcSEcCtD
Fluvoxamine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000653	0.00294	CcSEcCtD
Fluvoxamine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000647	0.00292	CcSEcCtD
Fluvoxamine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000641	0.00289	CcSEcCtD
Fluvoxamine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000633	0.00285	CcSEcCtD
Fluvoxamine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000628	0.00283	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000628	0.00283	CcSEcCtD
Fluvoxamine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000624	0.00281	CcSEcCtD
Fluvoxamine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000616	0.00277	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000615	0.00277	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000607	0.00274	CcSEcCtD
Fluvoxamine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000598	0.0027	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000572	0.00258	CcSEcCtD
Fluvoxamine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000568	0.00256	CcSEcCtD
Fluvoxamine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000564	0.00254	CcSEcCtD
Fluvoxamine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00056	0.00252	CcSEcCtD
Fluvoxamine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000558	0.00252	CcSEcCtD
Fluvoxamine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000553	0.00249	CcSEcCtD
Fluvoxamine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000546	0.00246	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000542	0.00244	CcSEcCtD
Fluvoxamine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000541	0.00244	CcSEcCtD
Fluvoxamine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000537	0.00242	CcSEcCtD
Fluvoxamine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000537	0.00242	CcSEcCtD
Fluvoxamine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000517	0.00233	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000513	0.00231	CcSEcCtD
Fluvoxamine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000499	0.00225	CcSEcCtD
Fluvoxamine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000496	0.00224	CcSEcCtD
Fluvoxamine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000496	0.00224	CcSEcCtD
Fluvoxamine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000463	0.00208	CcSEcCtD
Fluvoxamine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00045	0.00203	CcSEcCtD
Fluvoxamine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000444	0.002	CcSEcCtD
Fluvoxamine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00043	0.00194	CcSEcCtD
Fluvoxamine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000415	0.00187	CcSEcCtD
Fluvoxamine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000399	0.0018	CcSEcCtD
Fluvoxamine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.00178	CcSEcCtD
Fluvoxamine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000395	0.00178	CcSEcCtD
Fluvoxamine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000393	0.00177	CcSEcCtD
Fluvoxamine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000373	0.00168	CcSEcCtD
